MYOMO INC

NYSE: MYO (Myomo Inc.)

Last update: 2 hours ago

0.876

0.04 (4.39%)

Previous Close 0.839
Open 0.840
Volume 562,241
Avg. Volume (3M) 711,251
Market Cap 33,665,676
Price / Sales 0.840
Price / Book 2.23
52 Weeks Range
0.711 (-18%) — 6.44 (635%)
Earnings Date 10 Nov 2025
Profit Margin -15.05%
Operating Margin (TTM) -35.80%
Diluted EPS (TTM) -0.140
Quarterly Revenue Growth (YOY) 161.90%
Total Debt/Equity (MRQ) 38.14%
Current Ratio (MRQ) 2.66
Operating Cash Flow (TTM) -2.72 M
Levered Free Cash Flow (TTM) -2.37 M
Return on Assets (TTM) -12.72%
Return on Equity (TTM) -35.68%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock Myomo Inc. - -

AIStockmoo Score

-1.1
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators -2.5
Average -1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
MYO 34 M - - 2.23
CATX 363 M - - 1.31
SI 294 M - - 1.99
ELMD 250 M - 31.76 5.42
SENS 241 M - - 3.82
XTNT 89 M - 63.50 1.70

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Sector Healthcare
Industry Medical Devices
% Held by Insiders 7.05%
% Held by Institutions 60.47%

Ownership

Name Date Shares Held
Rosalind Advisors, Inc. 30 Sep 2025 3,790,788
Soleus Capital Management, L.P. 30 Sep 2025 704,275
Clearstead Advisors, Llc 30 Sep 2025 425,600

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria